节点文献

肠道菌群及其代谢产物在非酒精性脂肪性肝病发生发展及治疗中的作用

Role of intestinal microbiota and metabolites in the development, progression, and treatment of nonalcoholic fatty liver disease

  • 推荐 CAJ下载
  • PDF下载
  • 不支持迅雷等下载工具,请取消加速工具后下载。

【作者】 李永强唐文娟周永健

【Author】 LI Yongqiang;TANG Wenjuan;ZHOU Yongjian;Department of Gastroenterology, Guangzhou First People’s Hospital & The Second Affiliated Hospital of South China University of Technology;Guangzhou Digestive Disease Center;

【通讯作者】 周永健;

【机构】 广州市第一人民医院(华南理工大学附属第二医院)消化内科,广州消化疾病中心

【摘要】 非酒精性脂肪性肝病(NAFLD)是全世界最为常见的慢性肝病。肝脏与肠道之间有着紧密的结构及功能关系即“肠-肝轴”,其中肠道菌群可通过菌群易位、内源性乙醇的产生、胆汁酸和胆碱代谢的调节异常、内毒素血症等参与NAFLD的发生、发展。本文主要关注肠道菌群及代谢产物在NAFLD发生、发展及治疗中的作用进展。

【Abstract】 Nonalcoholic fatty liver disease(NAFLD) is the most common chronic liver disease around the world. There is a close structural and functional relationship between the liver and the intestine, namely “the gut-liver axis”, in which intestinal microbiota can participate in the development and progression of NAFLD through microbial translocation, production of endogenous ethanol, abnormal regulation of bile acid metabolism and choline metabolism, and endotoxemia. This article reviews the role of intestinal microbiota and metabolites in the development, progression, and treatment of NAFLD.

【基金】 国家自然科学基金(82170585,81970507);广州市医学重点学科(2021-2023);广州市科技计划项目(SL2022A03J01100);广东省自然科学基金(2021A1515011290)~~
  • 【文献出处】 临床肝胆病杂志 ,Journal of Clinical Hepatology , 编辑部邮箱 ,2023年08期
  • 【分类号】R575.5
  • 【下载频次】66
节点文献中: 

本文链接的文献网络图示:

本文的引文网络